Inventor · disambiguated record
Carl R. Merril
Also filed as: MERRIL CARL · MERRIL CARL R
30 granted patents·21 pending applications·839 citations·filing 1982–2024
98Inventor score
Files withUS HEALTH14ADAPTIVE PHAGE THERAPEUTICS INC8EXPONENTIAL BIOTHERAPIES INC6PANACEA PHARMACEUTICALS INC5MONOCLONETICS INT4
Top patents by PatentIndex Score
51 records- 0194US5688501AAntibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense systemEXPONENTIAL BIOTHERAPIES INC·Filed 1996·Granted Nov 18, 1997·112 cites·16 claims
- 0292US4555490ARapid visualization system for gel electrophoresisUS HEALTH·Filed 1984·Granted Nov 26, 1985·57 cites·10 claims
- 0387US5811093ABacteriophage genotypically modified to delay inactivations by the host defense systemEXPONENTIAL BIOTHERAPIES INC·Filed 1996·Granted Sep 22, 1998·72 cites·4 claims
- 0487US4405720ASilver stains for protein in gelsUS HEALTH·Filed 1982·Granted Sep 20, 1983·48 cites·16 claims
- 0586US7332307B2Antibacterial therapy with bacteriophage physico-chemically altered by pegylation to delay inactivation by the host defense systemUS HEALTH·Filed 2003·Granted Feb 19, 2008·12 cites·2 claims
- 0685US7399753B2Trans-splicing mediated photodynamic therapyVIRXSYS CORP·Filed 2003·Granted Jul 15, 2008·13 cites·15 claims
- 0784US5766892AAntibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system together with an antibioticEXPONENTIAL BIOTHERAPIES INC·Filed 1995·Granted Jun 16, 1998·41 cites·1 claims
- 0882US5468610AThree highly informative microsatellite repeat polymorphic DNA markersUS HEALTH·Filed 1993·Granted Nov 21, 1995·73 cites·12 claims
- 0981US5660812AAntibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense systemEXPONENTIAL BIOTHERAPIES INC·Filed 1995·Granted Aug 26, 1997·32 cites·1 claims
- 1079US9744223B2Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-β-hydroxylase)PANACEA PHARMACEUTICALS INC·Filed 2013·Granted Aug 29, 2017·4 cites·9 claims
- 1179US5817797ASequencing DNA; a modification of the polymerase chain reactionUS HEALTH·Filed 1988·Granted Oct 6, 1998·27 cites·7 claims
- 1279US5369004AFive highly informative microsatellite repeat polymorphic DNA markersUS HEALTH·Filed 1992·Granted Nov 29, 1994·59 cites·4 claims
- 1378US6740492B2High sensitivity phage display biomolecule detectionUS HEALTH·Filed 2001·Granted May 25, 2004·5 cites·5 claims
- 1478US5378602AHighly informative microsatellite repeat polymorphic DNA markers twenty-[seven]sixUS HEALTH·Filed 1991·Granted Jan 3, 1995·76 cites·4 claims
- 1574US7163818B2Bacteriophage having multiple host rangeUS HEALTH·Filed 2003·Granted Jan 16, 2007·7 cites·3 claims
- 1673US7521479B2Methods of treating prion disease in mammalsPANACEA PHARMACEUTICALS INC·Filed 2001·Granted Apr 21, 2009·3 cites·14 claims
- 1770US5844097AMethods for the diagnosis of peripheral nerve damageMONOCLONETICS INT·Filed 1995·Granted Dec 1, 1998·37 cites·2 claims
- 1869US11911345B2Phage dispensing systemADAPTIVE PHAGE THERAPEUTICS INC·Filed 2018·Granted Feb 27, 2024·1 cites·28 claims
- 1969US2024108551A1Phage dispensing systemADAPTIVE PHAGE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2068US4892814AMethod for distinguishing Creutzfeldt-Jakob disease from other dementiasUS HEALTH·Filed 1987·Granted Jan 9, 1990·28 cites·3 claims
- 2165US4940659AScreening extra-cellular body fluids for superoxide dismutase (SOD-1) for determining fetal trisomy 21 down syndromeMONOCLONETICS INT·Filed 1987·Granted Jul 10, 1990·23 cites·4 claims
- 2265US4703016ASilver stain for rapid, quantitative detection of polypeptides and nucleic acidsUS HEALTH·Filed 1986·Granted Oct 27, 1987·23 cites·5 claims
- 2363US10702591B2Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-beta-hydroxylasePANACEA PHARMACEUTICALS INC·Filed 2017·Granted Jul 7, 2020·0 cites·6 claims
- 2461US2024279620A1Method for purification of bacteriophage particlesADAPTIVE PHAGE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2559US2005063957A1Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense systemFiled 2004·Application pending·0 cites
- 2658US2009203143A1Trans-splicing mediated photodynamic therapyVIRXSYS CORP·Filed 2008·Application pending·0 cites
- 2758US2020246443A1Therapeutic cancer vaccine targeted to haah (aspartyl-[asparaginyl]-beta-hydroxylase)PANACEA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2857US5583201AMethods for diagnosis of peripheral nerve damageMONOCLONETICS INT·Filed 1994·Granted Dec 10, 1996·18 cites·1 claims
- 2957US2004161411A1Antibacterial therapy with bacteriophage genotypically modified to delay inactiovation by the host defense systemFiled 2003·Application pending·0 cites
- 3056US4508820AMethod for simultaneously monitoring turnover rate in multiple proteinsUS HEALTH·Filed 1984·Granted Apr 2, 1985·14 cites·4 claims
- 3154US5429947ADiagnosing Alzheimer's disease and schizophreniaFiled 1992·Granted Jul 4, 1995·18 cites·5 claims
- 3253US12006517B2Method for purification of bacteriophage particlesADAPTIVE PHAGE THERAPEUTICS INC·Filed 2022·Granted Jun 11, 2024·0 cites·19 claims
- 3352US5364793AMethods for the diagnosis of peripheral nerve damageMONOCLONETICS INT·Filed 1992·Granted Nov 15, 1994·15 cites·4 claims
- 3452US2017072034A1Therapeutic cancer vaccine targeted to haah (aspartyl-[asparaginyl]-beta-hydroxylase)PANACEA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3552US2001043917A1Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense systemFiled 2001·Application pending·0 cites
- 3652US2001026795A1Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense systemEXPONENTIAL BIOTHERAPIES INC·Filed 2001·Application pending·0 cites
- 3752US2021315197A1Preservation of phage concentration in clinical samplesADAPTIVE PHAGE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3850US5292665ACatalyst for preparing polyacrylamide gel which improves the detection of biomaterials by silver stainingUS ARMY·Filed 1992·Granted Mar 8, 1994·12 cites·15 claims
- 3950US2007207167A1Immunologically enhanced recombinant vaccinesMERRIL CARL R·Filed 2006·Application pending·0 cites
- 4050US2001043924A1Antibacterial therapy with bacteriophage physico-chemically altered to delay inactivation by the host defense systemEXPONENTIAL BIOTHERAPIES INC·Filed 2001·Application pending·0 cites
- 4150US2021332419A1Monitoring host cell contamination of virus-based biological productsADAPTIVE PHAGE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4248US2014271689A1Therapeutic Cancer Vaccine Targeted to HAAH (Aspartyl-[Asparaginyl]-beta-Hydroxylase)BISWAS BISWAJIT·Filed 2013·Application pending·0 cites
- 4347US2021369635A1Novel methods of vaccination using icosahedral phageADAPTIVE PHAGE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4445US5721100AThree highly informative microsatellite repeat polymorphic DNA markersUS HEALTH·Filed 1995·Granted Feb 24, 1998·6 cites·12 claims
- 4545US2021065844A1Methods to determine the sensitivity profile of a bacterial strain to a therapeutic compositionADAPTIVE PHAGE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4643US2005118567A1Method for determining sensitivity to a bacteriophageFiled 2003·Application pending·0 cites
- 4739US2002177614A1Methods for treating nuerodegenerative diseases including alzheimer'sFiled 2001·Application pending·0 cites
- 4837US2009155768A1Reporter plasmid phage packaging system for detection of bacteriaSCHOLL DEAN·Filed 2005·Application pending·0 cites
- 4934US5861504AEleven highly informative microsatelite repeat polymorphic DNA markersUS HEALTH·Filed 1992·Granted Jan 19, 1999·3 cites·5 claims
- 5031US2003026785A1Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense systemFiled 1997·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →